Princeton Global Asset Management LLC Novo Cure LTD Transaction History

Princeton Global Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$112.16 - $174.14 $56,080 - $87,070	-500 Closed	0 $0
Q1 2020 Apr 28, 2020	SELL	$57.05 - $95.75 $17,115 - $28,725	-300 Reduced 37.5%	500 $34,000
Q3 2019 Dec 03, 2019	SELL	$61.86 - $97.8 $12,372 - $19,560	-200 Reduced 20.0%	800 $59,000
Q2 2019 Sep 06, 2019	BUY	$42.22 - $63.23 $42,220 - $63,230	1,000 New	1,000 $63,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Global Asset Management LLC with notifications on news.